Scientists have found particular types of the disease could be vulnerable to this double-pronged attack.

The drugs involved are already used to treat other cancers – and can help slow tumour growth and kill off cancer cells.

Dr Adam Sharp, from The Institute of Cancer Research in Sutton, thinks this approach could be used more widely.